Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
They were only just moving past break even point on the hVivo business due to better occupancy and reduced costs, with the investment in c19 HCS and antibody testing it's actually quite a good sign that the levels of cash haven't gone down much
Helpful to me, I have a long term holding in a shares since hVivo days and I spreadbet the rises and falls as I'm sure others do, so discussing the new floor price is helpful
My guess is about 25p after a few days from this news, maybe it will hold the current price over the weekend but settle towards 25p as next week drags on and the traders chase other rainbows
Nope. Must be at the bottom soon though, I want to buy my spreadbet again...
The novel technology used to make the peptide based vaccine Flu-v and AGS-v could be used to make a covid vaccine. What the odds that Seek group are busy working on this in the background? A private company like that have no need to publicise their work via RNS...
Tiny volume and huge gains
A spread gives me 4:1 ish leverage, does it make more sense to buy a long spred or shares to benefit from the coming dividends?
I've never held a spread for a company that paid a dividend before
Still have 320000 in shares but closed £1500 per penny spread yesterday. Waiting to buy back the spread today...
Those who jumped on the bandwagon recently might jump off at these results
That's what the cash pile is for
"Within a month or two we are likely to have our quarantine clinic block booked out for the next 18 months to two years with conventional challenge study contracts"
Where will the covid studies go? New facility?
Good or bad news for SP this morning?
Volume looks tiny on IG, is something happening in the L2 to cause this rise?
IG have an app, set up an account first at ig.com
Codagenix are not one of the top 4 pharma CF has been talking about so those contracts are still to come
If he has sold Imutex it would be too late to buy, dividend will go to the holders on the date before the RNS surely
PrEP 001 is based on J&J intellectual property, no info on the terms of use of the IP in the public domain
Although the presence of antibodies in the blood can reveal if someone has been infected in the past with the virus, we do not know whether they offer full or partial protection against future infections. Protection may also depend on another part of the immune system, including the response of white blood cells called T-cells, which are not specifically measured by blood tests. This means the idea of an ‘antibody positive passport’, a document that allows people with antibodies to the virus to go back to work as they are presumed to be immune, should be considered with caution.
In addition, 10 to 20 per cent of people who have been infected with COVID-19 have little or no detectable antibody in their blood. However, this does not mean they have no immunity. In other diseases, such as flu, some people who appear to have no antibodies still have immunity through another part of the immune system, anti-viral T-cells. Understanding whether T-cells protect against future infection is key.
https://www.immunology.org/news/coronavirus-immunology-qa-what-you-need-know-about-our-new-report
I suppose it doesn't matter if it measures the wrong things as long as it shows who has been infected. However, if it only works on recent infections due to drop off in antibody levels, there might be work to be done on finding the biomarker of long term immunity
ORPH has turned a strange blue colour, don't know what it means?